Journal
UROLOGY
Volume 98, Issue -, Pages 14-20Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2016.08.013
Keywords
-
Categories
Funding
- Agency for Healthcare Research and Quality [HHSA2902012000071]
- U.S. Department of Health and Human Services
Ask authors/readers for more resources
The management of clinically localized renal masses suspicious for renal cell carcinoma varies, partially because of gaps in the evidence base. We conducted a systematic review to summarize research gaps for the evaluation of composite models for predicting malignancy; use of percutaneous renal sampling for diagnosis; and comparative effectiveness of surgery, thermal ablation, and active surveillance. A total of 147 studies, published in 150 articles, were identified. To promote improved patient care and health outcomes, we recommend incorporation of emerging biomarkers into validated composite models, standardization of biopsy protocols, standard reporting of clinical stage, and performance of prospective studies with objective selection criteria. (C) 2016 Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available